Pleo valuation hampers fundraising and retention

The real issue is that a lower private market price turns equity from a recruiting advantage into a reminder that upside has already been reset. Pleo was last funded at roughly $4.5B pre money in December 2021, while later internal marks and 2026 reporting pointed closer to $1.6B to $1.7B. After multiple layoff rounds, that makes stock grants harder to use for keeping engineers and product talent, because employees compare today’s paper upside with earlier expectations and with better funded rivals still hiring aggressively.1 2 3 4 5

• A downshifted valuation also raises the cost of new capital. If Pleo raises equity near recent marks, existing investors and employees absorb dilution at a lower price. If it tries to hold to the 2021 price, new investors need growth and margin evidence strong enough to bridge a very large gap.1 2 3 4
• The talent problem is practical, not theoretical. Equity works best when employees believe each grant could be worth meaningfully more in a few years. Three layoff rounds since 2022, including cuts in engineering and data, weaken that belief and make cash compensation more important, which presses margins.1 4
• Pleo is also being measured against stronger comps. Brex reached about $700M annualized revenue by August 2025 and near profitability, while Payhawk hit about $100M annualized revenue by July 2026. In that context, Pleo needs cleaner proof of durable growth and product depth, not just category presence, to earn a higher next round price.6 7 8

The next phase depends on converting Pleo from a card led growth story into a compounding software and automation story. If product expansion and steadier profitability keep building, equity can become attractive again from a lower base, and any future raise can be framed as funding renewed momentum rather than repairing a 2021 peak.4 6 8